CEO: Matthew R. Patterson

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.


Key numbers

Market Capitalization:1183948380
Shares Outstanding: 45783000
Float: 41569910.991000004
Next Earning Date:2020-02-25
TTm EPS: -3.9835
TTm Dividend Rate:
200 days moving average:33.78
50 days moving average: 28.44
One day percent Change: -4.58



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,